Neuromuscular Diseases and Respiratory Muscle Weakness

Neuromuscular diseases include a broad group of disorders that interfere with the nerves, muscles, neuromuscular junctions, spinal cord, or other structures required for effective breathing. Although the lungs may initially be normal, progressive weakness can impair ventilation, coughing, swallowing, and airway protection.

Respiratory complications may develop gradually or occur rapidly during an acute illness.

Understanding how neuromuscular weakness affects pulmonary function is essential for recognizing early deterioration, preventing secretion retention and aspiration, supporting ventilation, and identifying patients who may require noninvasive or invasive mechanical ventilation.

What Are Neuromuscular Diseases?

Neuromuscular diseases affect one or more components involved in producing normal skeletal muscle movement. Depending on the disorder, the abnormality may originate in the central nervous system, peripheral nerves, neuromuscular junction, or skeletal muscles themselves.

From a respiratory standpoint, the exact location of the disease is important because normal breathing requires coordinated activity throughout the nervous and muscular systems. Signals generated within the brainstem travel through the spinal cord and peripheral nerves to activate the diaphragm, intercostal muscles, accessory muscles, and other structures involved in breathing.

Neuromuscular diseases can interfere with several essential respiratory functions:

• Generation of adequate inspiratory force
• Production of normal tidal volume
• Maintenance of adequate minute ventilation
• Deep inspiration and lung expansion
• Effective coughing
• Secretion clearance
• Swallowing
• Glottic closure
• Upper-airway protection
• Ventilation during sleep

Note: When these functions become impaired, the patient may develop hypoventilation and respiratory failure even when the lungs themselves do not contain significant primary disease.

How Neuromuscular Disease Affects Breathing

Normal ventilation depends on more than healthy lung tissue. The respiratory system must generate enough pressure to expand the lungs and move air into and out of the alveoli.

The diaphragm is the primary muscle of inspiration. The intercostal and accessory respiratory muscles assist with expansion of the thoracic cage, particularly when ventilatory demand increases. Expiratory muscles, especially the abdominal muscles, become important during forceful exhalation and coughing. When these muscles become weak, the respiratory pump begins to fail.

Inspiratory Muscle Weakness

Inspiratory muscle weakness limits the patient’s ability to take a deep breath. Tidal volume may decrease, and the patient may compensate by breathing more rapidly.

This rapid, shallow breathing pattern may initially maintain minute ventilation, but it is less efficient and can increase the proportion of ventilation going to anatomical dead space. As weakness progresses, the patient may no longer generate sufficient tidal volume to maintain adequate alveolar ventilation.

Vital capacity also decreases because the patient cannot inhale or exhale as forcefully as normal.

Incomplete lung expansion may contribute to:

• Reduced lung volumes
• Atelectasis
• Reduced chest-wall mobility
• Increased work of breathing
• Reduced pulmonary compliance over time

Note: The respiratory muscles may eventually become unable to meet the patient’s ventilatory demands.

Expiratory Muscle Weakness

Expiratory muscles are particularly important for coughing. A strong cough requires the patient to generate substantial intrathoracic pressure before rapidly expelling air from the lungs. Weak abdominal and expiratory muscles reduce cough force. As a result, mucus may remain within the airways instead of being expelled.

Retained secretions increase the risk of:

• Mucus plugging
• Airway obstruction
• Atelectasis
• Pneumonia
• Hypoxemia
• Increased work of breathing
• Acute respiratory failure

Note: A respiratory infection that produces only minor problems in a healthy person can become dangerous in a patient with neuromuscular weakness because the patient may not be able to clear the additional secretions.

Bulbar Muscle Weakness

Bulbar muscles control several functions involving the mouth, pharynx, larynx, and upper airway.

Weakness may impair:

• Swallowing
• Speech
• Glottic closure
• Airway protection
• Coughing

Note: Patients may cough or choke while eating and drinking. These findings should raise concern for aspiration. Aspiration is particularly dangerous when respiratory muscles are also weak because the patient may not have enough cough strength to clear aspirated material from the airways.

Progression of Respiratory Dysfunction

Respiratory deterioration in chronic neuromuscular disease often follows a recognizable pattern.Early muscle weakness may cause incomplete lung expansion and reduced vital capacity. As inspiratory and expiratory muscle function declines, coughing becomes less effective and secretions begin to accumulate.

Sleep-related respiratory abnormalities frequently develop before daytime respiratory failure. Nocturnal hypoventilation may occur because sleep naturally reduces ventilatory drive and respiratory muscle activity.

As disease progresses, the patient may develop:

• Reduced inspiratory capacity
• Reduced cough strength
• Retained secretions
• Atelectasis
• Sleep-disordered breathing
• Nocturnal hypoventilation
• Daytime hypercapnia
• Chronic ventilatory failure

Note: Bulbar weakness may occur at any point and further increase the risk of aspiration and pneumonia. Acute infections can dramatically accelerate this process. A patient who is stable at baseline may develop severe respiratory failure after pneumonia, influenza, another viral infection, or a sudden increase in airway secretions.

Signs and Symptoms of Respiratory Muscle Weakness

Early symptoms may be mild and nonspecific. Patients can appear relatively comfortable at rest despite significant reductions in respiratory reserve.

Exertional Dyspnea

Shortness of breath during activity is often one of the earliest symptoms. Respiratory muscles that can meet resting demands may become inadequate when ventilation must increase during exertion.

Orthopnea

Orthopnea is shortness of breath that worsens when lying flat. It is particularly important in neuromuscular disease because it may indicate diaphragmatic weakness.

When a patient lies supine, abdominal contents move upward and place additional pressure against the diaphragm. A healthy diaphragm can overcome this load, but a weakened diaphragm may not. Patients with significant diaphragmatic dysfunction often prefer sleeping upright or with the head elevated.

Other Symptoms

Additional findings may include:

• Fatigue
• Rapid, shallow breathing
• Weak voice
• Poor sleep
• Morning headaches
• Daytime sleepiness
• Weak cough
• Difficulty clearing mucus
• Frequent respiratory infections
• Choking during meals
• Difficulty swallowing
• Reduced exercise tolerance
• Paradoxical breathing movements

Note: Morning headaches and daytime drowsiness may reflect nocturnal carbon dioxide retention.

Pulmonary Function Testing in Neuromuscular Disease

Pulmonary function testing is an important method of identifying and monitoring respiratory muscle weakness. The typical pattern is restrictive rather than obstructive.

Restrictive Ventilatory Pattern

Common pulmonary function findings include reductions in:

• Vital capacity
• Forced vital capacity
• FEV1
• Total lung capacity

FEV1 may decrease because the patient cannot generate a large breath or forceful expiration, not because airway obstruction is necessarily present.

Residual volume may remain relatively preserved or become elevated as weakness progresses. Because total lung capacity decreases while residual volume remains relatively high, the RV/TLC ratio may increase.

This pattern differs from restrictive lung disease caused by pulmonary fibrosis. In fibrosis, the lung tissue itself is stiff. In neuromuscular disease, restriction primarily occurs because the respiratory muscles cannot generate enough force to fully inflate and empty the lungs.

Serial Measurements

A single pulmonary function measurement provides useful information, but trends are often more valuable. Progressive decreases in the following may indicate worsening respiratory muscle weakness:

• Vital capacity
• Tidal volume
• MIP
• MEP
• Peak cough flow

Note: Serial measurements are especially important in progressive diseases such as amyotrophic lateral sclerosis, muscular dystrophy, Guillain-Barré syndrome, and myasthenia gravis.

Sitting and Supine Vital Capacity

Measuring vital capacity in different body positions can help identify diaphragm dysfunction. In healthy individuals, moving from an upright to a supine position generally produces only a small decrease in vital capacity, often around 3% to 8%.

A decrease greater than approximately 10% may suggest diaphragmatic weakness. Patients with more severe diaphragm dysfunction may demonstrate a much larger decline.

This test can be particularly useful when a patient reports orthopnea despite relatively acceptable pulmonary function measurements while sitting upright.

Maximum Inspiratory Pressure

Maximum inspiratory pressure, or MIP, evaluates inspiratory muscle strength. The patient exhales toward residual volume and then attempts to inhale as forcefully as possible against an occluded airway. Because inspiration produces subatmospheric pressure, MIP is expressed as a negative pressure.

A stronger patient generates a more negative value. For example, a MIP of −80 cm H₂O reflects greater inspiratory strength than a MIP of −20 cm H₂O.

Healthy adults generally generate inspiratory pressures more negative than approximately:

• −50 cm H₂O in women
• −75 cm H₂O in men

Note: Values vary with age, body size, technique, and patient effort. In a deteriorating neuromuscular patient, a MIP of only approximately −20 to −25 cm H₂O represents severe weakness and should raise concern for impending ventilatory failure.

Maximum Expiratory Pressure

Maximum expiratory pressure, or MEP, measures expiratory muscle strength. The patient first inhales toward total lung capacity and then exhales forcefully against an occluded airway. MEP is recorded as a positive pressure.

Healthy adults commonly generate values greater than approximately:

• 80 cm H₂O in women
• 100 cm H₂O in men

Note: A reduced MEP suggests weakness of the abdominal muscles and other muscles involved in forceful expiration. This finding is clinically important because inadequate expiratory pressure contributes to poor cough effectiveness.

Limitations of MIP and MEP

MIP and MEP depend heavily on patient cooperation. Low measurements can result from:

• Poor effort
• Inadequate understanding
• Mouth leaks
• Facial weakness
• Poor technique
• Inability to maintain a mouthpiece seal

Note: Several acceptable and reproducible attempts should therefore be obtained. Patients with severe bulbar weakness may be unable to form an adequate seal around the mouthpiece. Alternative measurements such as sniff inspiratory pressure may be useful in these situations.

Maximum Voluntary Ventilation

Maximum voluntary ventilation, or MVV, measures the maximum amount of air the patient can move during rapid and deep breathing.

MVV depends on:

• Respiratory muscle strength
• Respiratory muscle endurance
• Airway resistance
• Lung mechanics
• Coordination
• Patient effort

Note: A low MVV may occur in obstructive lung disease, but it may also be reduced in neuromuscular disorders. If the MVV is disproportionately low compared with the FEV1, neuromuscular weakness or inadequate effort may be considered.

Blood Gas Changes and Hypoventilation

Early neuromuscular respiratory disease may not cause major abnormalities in arterial blood gases. Some patients initially breathe rapidly and develop mild hyperventilation, which can produce respiratory alkalosis.

As muscle weakness progresses, however, alveolar ventilation decreases. Carbon dioxide begins to accumulate, causing:

• Increased PaCO₂
• Respiratory acidosis
• Eventual hypoxemia

Hypercapnia is an important sign because neuromuscular respiratory failure is primarily a ventilatory problem.

A PaCO₂ of approximately 55 mm Hg or higher in a patient who is not normally hypercapnic should raise concern for significant ventilatory failure, particularly when combined with worsening pulmonary mechanics.

Oxygen saturation alone may be misleading. A patient can maintain an acceptable oxygen saturation while carbon dioxide continues to rise.

Sleep-Related Hypoventilation

Sleep is often the first time significant respiratory insufficiency becomes apparent. During sleep, ventilatory drive decreases and accessory respiratory muscle activity is reduced. These normal physiologic changes may expose respiratory weakness that is compensated for during the day.

Patients may develop:

• Obstructive sleep apnea
• Sleep-related hypoventilation
• Nocturnal oxygen desaturation
• Nocturnal hypercapnia
• Frequent awakenings

Symptoms can include poor sleep quality, morning headaches, fatigue, and excessive daytime sleepiness.

Polysomnography provides the most comprehensive assessment because it evaluates sleep stages, breathing patterns, oxygen saturation, carbon dioxide levels, and arousals. Other monitoring methods may include overnight oximetry and capnography.

Evaluating Cough Effectiveness

An effective cough requires several coordinated steps:

• Inspiratory Phase: The patient takes a deep breath to create a large volume of air behind the material that needs to be cleared.
• Compressive Phase: The glottis closes while expiratory muscles contract, generating high intrathoracic pressure.
• Expulsive Phase: The glottis opens and high-velocity expiratory airflow moves mucus toward the upper airway.

Note: Neuromuscular disease can interfere with every phase. Inspiratory weakness limits the volume of air available for coughing. Bulbar weakness can impair glottic closure. Expiratory weakness reduces the pressure needed to generate rapid airflow.

Peak Cough Flow

Peak cough flow provides an objective measurement of cough strength. In adults with neuromuscular disease, cough assistance is commonly considered when peak cough flow falls below approximately 270 L/min.

A peak cough flow below approximately 160 L/min is associated with severely impaired secretion clearance. These values should be considered together with the patient’s clinical condition, secretion burden, and ability to protect the airway.

Assisted Cough Techniques

Patients who cannot cough effectively may require assistance.

Manually Assisted Cough

A quad cough involves applying gentle pressure over the upper abdomen while the patient attempts to cough. The patient takes a deep breath and holds it. As the patient coughs, pressure is applied below the xiphoid region to increase expiratory force.

Quad coughing should generally be avoided in patients with conditions such as:

• Recent meals
• High aspiration risk
• Pregnancy
• Recent upper abdominal surgery
• Hiatal hernia
• Abdominal aortic aneurysm

Lateral Chest Compression

Lateral chest compression may be used when abdominal pressure is inappropriate. The therapist applies inward pressure over the lateral chest during the cough.

This technique should be avoided in patients with:

• Rib fractures
• Flail chest
• Severe osteoporosis

Assisted Inspiration

A manual resuscitation bag may be used to provide a larger inspiratory volume before coughing. Increasing inspiratory volume gives the patient more air to generate expiratory flow during the cough.

This technique can be performed using a mask in patients with a natural airway or through an artificial airway when an endotracheal or tracheostomy tube is present.

Mechanical Insufflation-Exsufflation

Mechanical insufflation-exsufflation is an important airway-clearance therapy for patients who cannot generate an effective cough. The device first delivers positive pressure to inflate the lungs. It then rapidly switches to negative pressure, producing a high expiratory flow that simulates a natural cough.

Typical adult pressures may approach:

• +30 to +50 cm H₂O during insufflation
• −30 to −50 cm H₂O during exsufflation

Pressures around +40 and −40 cm H₂O are commonly effective in adults, although therapy should usually begin at lower settings and be adjusted according to tolerance and effectiveness.

Each phase may last approximately one to three seconds. Several cycles can be delivered before allowing the patient to rest, cough, or undergo suctioning. Mechanical insufflation-exsufflation is commonly used in patients with conditions such as ALS, spinal cord injury, poliomyelitis, muscular dystrophy, and myasthenia gravis.

Lung Volume Recruitment

Patients with chronic neuromuscular weakness may benefit from techniques designed to periodically expand the lungs beyond their usual spontaneous tidal volume.

These techniques can help:

• Maintain chest-wall mobility
• Improve lung expansion
• Reduce atelectasis
• Preserve inspiratory capacity
• Improve cough effectiveness

Note: Breath stacking is one method. The patient takes several consecutive inspirations without fully exhaling between breaths, gradually increasing lung volume. Manual resuscitation-bag inflation may also be used to assist lung expansion.

Swallowing and Aspiration

Bulbar weakness should be taken seriously because it increases the risk of aspiration.

Warning signs include:

• Coughing while eating
• Choking while drinking
• Wet or gurgling voice after swallowing
• Recurrent pneumonia
• Difficulty managing oral secretions
• Unexplained weight loss

Formal swallowing evaluation may include videofluoroscopy. Simple bedside observation can also provide useful information. Coughing immediately after swallowing water may suggest impaired airway protection.

Aspiration pneumonia can rapidly destabilize a neuromuscular patient because infection increases respiratory workload while weak respiratory muscles limit the ability to compensate.

Nutrition and Respiratory Muscle Strength

Nutrition is an important part of respiratory management. Bulbar weakness may make eating slow, difficult, or unsafe. Patients may reduce food intake because swallowing requires excessive effort or causes choking. Malnutrition can worsen skeletal and respiratory muscle weakness.

This may create a cycle:

1. Neuromuscular weakness makes eating difficult.
2. Caloric intake decreases.
3. Weight and muscle mass decline.
4. Respiratory muscles become weaker.
5. Breathing and swallowing become even more difficult.

Note: Nutritional supplementation or feeding-tube placement may be considered when appropriate for the patient’s clinical condition and goals of care.

Noninvasive Ventilation

Noninvasive ventilation is a major treatment for chronic neuromuscular respiratory weakness. Ventilatory support often begins during sleep because nocturnal hypoventilation commonly develops before daytime ventilatory failure. NIV reduces the workload placed on weakened respiratory muscles while improving alveolar ventilation.

Potential benefits include:

• Reduced hypercapnia
• Improved sleep
• Reduced work of breathing
• Improved daytime symptoms
• Improved ventilation
• Reduced respiratory muscle fatigue
• Prolonged survival in selected progressive disorders

Note: As disease advances, patients may require ventilatory assistance for increasing portions of the day.

Invasive Mechanical Ventilation

Some patients eventually become unable to maintain ventilation, airway protection, or secretion clearance using noninvasive methods alone. Endotracheal intubation or tracheostomy may then become necessary.

Mechanical ventilation does not correct the underlying neuromuscular disease. Instead, it provides ventilatory support while the underlying condition improves or while long-term support is required. The decision to initiate invasive ventilation depends on multiple findings rather than a single number.

Concerning findings include:

• Apnea
• Progressive hypercapnia
• Vital capacity below approximately 10 to 15 mL/kg
• MIP weaker than approximately −20 to −25 cm H₂O
• Severe tachypnea or bradypnea
• Progressive respiratory distress
• Inability to clear secretions
• Severe bulbar dysfunction
• Worsening neurologic status
• Hypoxemia associated with instability
• Progressive cardiopulmonary deterioration

Supplemental Oxygen Considerations

Supplemental oxygen should be used carefully in patients whose primary problem is hypoventilation. Oxygen can correct hypoxemia without correcting inadequate alveolar ventilation.

A patient may therefore appear better because oxygen saturation improves while PaCO₂ continues to rise. Respiratory management should focus on correcting the underlying ventilatory failure when hypoventilation is present rather than relying on oxygen alone.

Guillain-Barré Syndrome

Guillain-Barré syndrome is an acute inflammatory neuropathy involving peripheral nerves and spinal roots. It often develops after an infection. Campylobacter jejuni and certain viral illnesses are recognized preceding events. The typical pattern is rapidly progressive, symmetrical ascending weakness.

Additional findings may include:

• Decreased or absent deep tendon reflexes
• Sensory abnormalities
• Dysphagia
• Reduced gag reflex
• Respiratory weakness
• Autonomic instability

Dysautonomia can cause major fluctuations in blood pressure and cardiac rhythm. Respiratory status must be monitored closely because weakness can progress rapidly. Serial measurements of vital capacity, MIP, MEP, cough strength, and respiratory pattern can help identify impending failure before severe blood gas abnormalities appear.

Mechanical ventilation may be required when the patient can no longer ventilate, clear secretions, or protect the airway.

Myasthenia Gravis

Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission. Antibodies interfere with acetylcholine receptors at the neuromuscular junction, producing characteristic muscle fatigability. Weakness is generally episodic and may worsen with repeated muscle use.

Common findings include:

• Ptosis
• Diplopia
• Ophthalmoplegia
• Dysphagia
• Weak voice
• Facial weakness
• Respiratory muscle weakness

Deep tendon reflexes usually remain normal. A myasthenic crisis is a severe exacerbation that can cause life-threatening respiratory muscle weakness.

Potential triggers include infection, surgery, childbirth, and medication-related problems. Patients in crisis may require mechanical ventilation until neuromuscular function improves.

Muscular Dystrophy

Muscular dystrophy is an inherited disorder characterized by progressive skeletal muscle degeneration and weakness. Duchenne muscular dystrophy is one of the most important examples.

It is an X-linked disorder caused by abnormal dystrophin and occurs predominantly in males. Children initially develop weakness affecting activities such as running, climbing stairs, and walking. As the disease progresses, respiratory muscles become involved.

Respiratory complications include:

• Reduced vital capacity
• Reduced inspiratory strength
• Weak cough
• Nocturnal hypoventilation
• Recurrent respiratory infections
• Progressive respiratory failure

Note: Becker muscular dystrophy is related to Duchenne muscular dystrophy but usually progresses more slowly. Serial pulmonary function testing, cough assessment, sleep evaluation, airway-clearance support, and noninvasive ventilation are important components of respiratory management.

Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis is a progressive motor neuron disease that eventually affects inspiratory, expiratory, and bulbar muscles. Respiratory symptoms may begin with exertional dyspnea. As diaphragm weakness progresses, orthopnea often develops.

Bulbar involvement may cause:

• Dysphagia
• Coughing during meals
• Aspiration
• Poor secretion clearance
• Weak voice

Serial measurements of vital capacity and respiratory muscle strength help track disease progression. Noninvasive ventilation frequently becomes an important part of long-term respiratory management.

Acute pneumonia or another respiratory infection can cause rapid deterioration because these patients may already have very limited respiratory reserve.

Spinal Muscular Atrophy

Spinal muscular atrophy is a motor-neuron disorder associated with progressive muscle weakness. Respiratory involvement varies considerably according to disease severity. Children with severe forms may develop respiratory weakness early in life, while less severe forms may progress more gradually.

Weakness of the inspiratory and expiratory muscles increases the risk of hypoventilation, weak cough, secretion retention, recurrent infection, and respiratory failure. Sleep evaluation and cough assessment are particularly important because abnormalities may appear before obvious daytime respiratory distress.

Diaphragm Paralysis

Diaphragm paralysis can be unilateral or bilateral. Unilateral paralysis may result from injury to a phrenic nerve caused by trauma, surgery, or a tumor. Bilateral paralysis produces much more severe respiratory impairment.

Patients may experience pronounced orthopnea and a significant decrease in vital capacity when moving from sitting to supine. Imaging, fluoroscopy, respiratory pressure measurements, and positional spirometry may assist with diagnosis.

Tetanus

Tetanus is caused by a toxin produced by Clostridium tetani. Unlike diseases characterized by flaccid weakness, tetanus produces severe muscular rigidity and painful spasms.

Important manifestations include:

• Trismus
• Dysphagia
• Risus sardonicus
• Neck stiffness
• Opisthotonus
• Rigid abdominal muscles
• Autonomic instability
• Reflex spasms triggered by light, sound, or touch

Respiratory compromise can result from severe muscle spasms, laryngospasm, or impaired ventilation. Treatment may involve tetanus immunoglobulin, wound debridement, antibiotics such as metronidazole, benzodiazepines, and medications to control severe muscle spasms.

Patients with severe respiratory compromise may require intubation, mechanical ventilation, and intensive care.

Botulism

Botulism is another neuromuscular disorder that can cause severe paralysis. Respiratory muscle involvement may progress to the point that spontaneous ventilation is no longer adequate.

As with other neuromuscular conditions, respiratory care focuses on supporting ventilation and airway clearance while the underlying neurologic disorder is treated.

Weaning From Mechanical Ventilation

Patients recovering from acute neuromuscular weakness require careful assessment before ventilator support is reduced.

Variables that may be evaluated include:

• Respiratory rate
• Tidal volume
• Vital capacity
• MIP
• Minute ventilation
• Gas exchange
• Cough effectiveness
• Secretion burden
• Mental status
• Airway protection

A vital capacity greater than approximately 10 mL/kg and adequate inspiratory pressure may suggest improving respiratory reserve, but no single measurement determines readiness for liberation. Respiratory muscle fatigue is a major reason for weaning failure.

When ventilator support is reduced, the patient must assume a greater share of the work of breathing. If respiratory workload exceeds available muscle strength, the patient may develop tachypnea, shallow breathing, distress, hypercapnia, and eventual ventilatory failure.

Recovery should therefore be demonstrated by sustained improvement rather than isolated favorable measurements.

Respiratory Care Priorities

Successful respiratory management of neuromuscular disease requires ongoing surveillance. Important priorities include:

• Monitoring vital capacity
• Measuring inspiratory and expiratory pressures
• Comparing sitting and supine pulmonary function when appropriate
• Monitoring carbon dioxide levels
• Identifying nocturnal hypoventilation
• Assessing cough strength
• Evaluating swallowing and aspiration risk
• Assisting secretion clearance
• Maintaining lung volume
• Supporting adequate nutrition
• Treating respiratory infections promptly
• Initiating noninvasive ventilation when indicated
• Providing invasive ventilation when necessary

Note: The goal is to identify deterioration before the patient reaches severe respiratory failure.

Neuromuscular Diseases Practice Questions

1. What is the primary respiratory problem associated with neuromuscular diseases?
Weakness or paralysis of the respiratory muscles can impair ventilation, coughing, secretion clearance, and airway protection.

2. Why can a patient with neuromuscular disease develop respiratory failure even when the lungs are initially normal?
The respiratory muscles and neurologic pathways responsible for ventilation may become too weak to generate adequate tidal volume and alveolar ventilation.

3. What pulmonary function pattern is commonly seen in neuromuscular disease?
A restrictive ventilatory pattern with reduced vital capacity and total lung capacity.

4. Why does vital capacity decrease in patients with neuromuscular weakness?
Weakened inspiratory and expiratory muscles cannot fully expand or empty the lungs.

5. What may happen to residual volume as neuromuscular weakness progresses?
Residual volume may remain relatively preserved or become elevated as expiratory muscle weakness worsens.

6. What does a significant decrease in vital capacity when moving from sitting to supine suggest?
Diaphragmatic weakness or dysfunction.

7. Approximately how much does vital capacity normally decrease when a healthy person moves from sitting to supine?
About 3% to 8%.

8. What positional decrease in vital capacity may suggest diaphragm dysfunction?
A decrease greater than approximately 10% when moving from sitting to supine.

9. What symptom commonly suggests significant diaphragmatic weakness?
Orthopnea

10. What does maximum inspiratory pressure measure?
The strength of the inspiratory muscles.

11. Why is maximum inspiratory pressure recorded as a negative value?
Because the patient generates subatmospheric pressure while inhaling against an occluded airway.

12. Which MIP value represents greater inspiratory muscle strength: −20 cm H₂O or −80 cm H₂O?
−80 cm H₂O

13. What MIP range may indicate severe respiratory muscle weakness and possible need for ventilatory support?
A MIP weaker than approximately −20 to −25 cm H₂O.

14. What does maximum expiratory pressure measure?
The strength of the expiratory muscles used during forceful exhalation and coughing.

15. Why is a reduced MEP clinically important in neuromuscular disease?
It indicates expiratory muscle weakness that can reduce cough effectiveness and impair secretion clearance.

16. Why should MIP and MEP results be interpreted cautiously?
They depend heavily on patient effort, cooperation, technique, and the ability to maintain a tight mouthpiece seal.

17. What respiratory complication often develops before daytime hypoventilation in neuromuscular disease?
Sleep-related hypoventilation

18. What symptoms may suggest nocturnal hypoventilation?
Morning headaches, poor sleep, fatigue, and daytime drowsiness.

19. What is the most comprehensive test for evaluating sleep-disordered breathing in neuromuscular disease?
Polysomnography

20. What blood gas abnormality develops as alveolar ventilation becomes inadequate?
Hypercapnia with respiratory acidosis.

21. Why can supplemental oxygen alone be inadequate in neuromuscular respiratory failure?
It may improve oxygen saturation without correcting hypoventilation or rising carbon dioxide levels.

22. What are the three major phases of an effective cough?
The inspiratory phase, compressive phase, and expulsive phase.

23. At what adult peak cough flow should cough-assistance techniques commonly be considered?
Below approximately 270 L/min.

24. What adult peak cough flow is associated with severely impaired secretion clearance?
Below approximately 160 L/min.

25. How does mechanical insufflation-exsufflation help a patient with neuromuscular weakness?
It provides positive pressure to inflate the lungs and then rapidly applies negative pressure to create expiratory flow that helps move secretions toward the upper airway.

26. Why are serial pulmonary function measurements especially useful in progressive neuromuscular disease?
They help identify gradual deterioration in respiratory muscle strength and ventilatory capacity over time.

27. What bedside measurements are commonly followed in a patient with progressive neuromuscular weakness?
Tidal volume, vital capacity, MIP, MEP, respiratory rate, and cough effectiveness.

28. Why can an acute respiratory infection cause rapid deterioration in a patient with neuromuscular disease?
It increases respiratory workload and secretion production in a patient who may already have very limited ventilatory reserve.

29. What is a common early symptom of respiratory muscle weakness during activity?
Exertional dyspnea

30. What breathing pattern may develop as inspiratory muscle weakness worsens?
Rapid, shallow breathing

31. Why does ineffective coughing increase the risk of atelectasis?
Retained secretions can obstruct airways and prevent normal ventilation of affected lung regions.

32. How can bulbar weakness increase the risk of pneumonia?
It can impair swallowing and airway protection, allowing food, liquid, or secretions to be aspirated.

33. What bedside finding during drinking may suggest aspiration?
Coughing immediately after swallowing.

34. What formal test may be used to evaluate swallowing and aspiration risk?
Videofluoroscopic swallowing evaluation.

35. Why can malnutrition worsen respiratory function in neuromuscular disease?
Loss of muscle mass and inadequate nutrition can further weaken the respiratory muscles.

36. What is the purpose of lung volume recruitment techniques?
They help maintain lung expansion, preserve chest-wall mobility, reduce atelectasis, and support cough effectiveness.

37. What is breath stacking?
It is a technique in which several consecutive inspirations are taken without fully exhaling between breaths to increase lung volume.

38. Why is noninvasive ventilation often started during sleep?
Nocturnal hypoventilation commonly develops before daytime ventilatory failure.

39. What is a major benefit of noninvasive ventilation in neuromuscular disease?
It reduces the work placed on weakened respiratory muscles while improving alveolar ventilation.

40. When may invasive mechanical ventilation become necessary?
When the patient can no longer maintain adequate ventilation, airway protection, or secretion clearance with noninvasive methods.

41. What vital capacity range may suggest inadequate pulmonary mechanics and possible need for ventilatory support?
Approximately less than 10 to 15 mL/kg.

42. Why should clinicians not wait for severe blood gas abnormalities before acting in rapidly progressive neuromuscular weakness?
Respiratory muscle failure may be advanced before marked hypercapnia or hypoxemia appears.

43. What pattern of weakness is characteristic of Guillain-Barré syndrome?
Rapidly progressive, symmetrical ascending weakness.

44. What happens to deep tendon reflexes in Guillain-Barré syndrome?
They are typically decreased or absent.

45. What autonomic complication is especially important in Guillain-Barré syndrome?
Dysautonomia with blood pressure fluctuations and cardiac arrhythmias.

46. What pattern of weakness is typical of myasthenia gravis?
Fluctuating, fatigable weakness that often becomes worse with repeated muscle use.

47. What ocular findings are commonly associated with myasthenia gravis?
Ptosis, diplopia, and ophthalmoplegia.

48. What is a myasthenic crisis?
A severe worsening of muscle weakness that can produce life-threatening respiratory failure.

49. What is the inheritance pattern of Duchenne muscular dystrophy?
X-linked recessive.

50. Why does respiratory failure eventually develop in Duchenne muscular dystrophy?
Progressive skeletal and respiratory muscle weakness reduces ventilation, cough strength, and respiratory reserve.

51. What protein is absent in Duchenne muscular dystrophy?
Dystrophin

52. How does Becker muscular dystrophy generally differ from Duchenne muscular dystrophy?
Becker muscular dystrophy usually progresses more slowly and follows a less severe course.

53. What respiratory symptom may appear early in amyotrophic lateral sclerosis?
Exertional dyspnea

54. What symptom often develops in ALS as diaphragmatic weakness becomes more severe?
Orthopnea

55. Why are patients with ALS at increased risk for aspiration?
Bulbar muscle weakness can impair swallowing and airway protection.

56. What is the primary respiratory concern in spinal muscular atrophy?
Progressive respiratory muscle weakness that can lead to hypoventilation, weak cough, and respiratory failure.

57. Why are sleep studies especially important in children with neuromuscular disease?
Nocturnal hypoventilation may develop before obvious daytime respiratory failure.

58. What is the main respiratory effect of bilateral diaphragm paralysis?
Severe ventilatory impairment with prominent orthopnea and reduced supine vital capacity.

59. What structure may be damaged in unilateral diaphragm paralysis?
The phrenic nerve.

60. What types of events can cause phrenic nerve injury?
Trauma, surgery, or tumor involvement.

61. What microorganism causes tetanus?
Clostridium tetani

62. How does tetanus affect motor control?
Its toxin blocks inhibitory motor pathways, causing severe muscle rigidity and painful spasms.

63. What is trismus?
Severe contraction of the jaw muscles, commonly called lockjaw.

64. What is opisthotonus?
Severe muscle spasm that causes the head and heels to arch backward.

65. What is risus sardonicus?
An abnormal fixed grin caused by facial muscle spasms in tetanus.

66. Why can minor stimuli be dangerous in severe tetanus?
Light, noise, or touch can trigger powerful reflex muscle spasms.

67. What treatment should be given promptly after tetanus is diagnosed?
Intramuscular tetanus immunoglobulin.

68. What antibiotic may be used to control Clostridium tetani growth?
Metronidazole

69. Why may mechanical ventilation be required when neuromuscular blocking agents are used for severe tetanus?
The medications paralyze skeletal muscles, including the respiratory muscles.

70. What is the primary respiratory danger of botulism?
Progressive paralysis can weaken the respiratory muscles enough to cause ventilatory failure.

71. Why may a weak voice be an important finding in neuromuscular disease?
It can indicate weakness of the respiratory or bulbar muscles.

72. What does paradoxical abdominal or thoracic movement suggest?
Advanced respiratory muscle or diaphragmatic weakness.

73. Why can chronic neuromuscular weakness reduce chest-wall mobility?
Repeated incomplete lung expansion can contribute to progressive stiffness of the rib cage.

74. What role does suctioning play in neuromuscular respiratory care?
It helps remove secretions when the patient cannot clear them effectively with coughing alone.

75. Why must secretion management remain a priority even when ventilatory support is adequate?
Mechanical ventilation can support breathing, but it does not restore an ineffective cough or remove retained airway secretions.

76. Why may FEV1 decrease in neuromuscular disease even without primary airway obstruction?
Because respiratory muscle weakness limits the patient’s ability to generate a full inspiration and forceful expiration.

77. Why can the RV/TLC ratio become elevated in neuromuscular disease?
Residual volume may remain relatively preserved while total lung capacity decreases.

78. What does a progressively rising PaCO₂ indicate in a patient with neuromuscular weakness?
Worsening alveolar hypoventilation and declining ventilatory muscle function.

79. Why can oxygen saturation appear acceptable despite worsening neuromuscular respiratory failure?
Carbon dioxide may rise before significant oxygen desaturation develops.

80. What alternative respiratory muscle test may be useful when bulbar weakness prevents a good mouthpiece seal?
Sniff inspiratory pressure.

81. What does maximal voluntary ventilation assess in a patient with suspected neuromuscular weakness?
Overall ventilatory performance, including respiratory muscle strength, endurance, coordination, and breathing capacity.

82. Why may MVV be disproportionately reduced in neuromuscular disease?
Weak respiratory muscles may limit rapid, deep breathing even when airway obstruction is not severe.

83. What is one reason functional residual capacity may remain normal in some patients with neuromuscular disease?
Early respiratory muscle weakness may reduce other lung volumes before significantly altering functional residual capacity.

84. How can scoliosis worsen respiratory problems in neuromuscular disease?
It can further restrict chest-wall movement and increase the mechanical load on weakened respiratory muscles.

85. Why is glottic closure important for an effective cough?
It allows intrathoracic pressure to build before rapid expiratory airflow is released.

86. What role do the abdominal muscles play during coughing?
They contract during the compressive and expulsive phases to generate high expiratory pressure.

87. What is the purpose of a quad cough?
To augment expiratory force by applying external abdominal pressure during the patient’s cough.

88. Why should a quad cough generally be avoided shortly after a patient has eaten?
Abdominal compression can increase the risk of regurgitation and aspiration.

89. When is lateral chest compression preferred over abdominal compression?
When abdominal pressure is contraindicated but external assistance is still needed to strengthen the cough.

90. Why is lateral chest compression contraindicated in patients with flail chest?
External chest compression may worsen chest-wall injury and instability.

91. What is the purpose of assisted inspiration before a cough?
To provide a larger inspiratory volume so the patient can generate stronger expiratory airflow.

92. What pressure pattern is used during mechanical insufflation-exsufflation?
Positive pressure during insufflation followed rapidly by negative pressure during exsufflation.

93. Why should mechanical insufflation-exsufflation pressures be individualized?
Tolerance, disease severity, airway mechanics, and cough effectiveness vary among patients.

94. What does a weak gag reflex suggest in a patient with neuromuscular disease?
Bulbar dysfunction with increased risk of impaired airway protection and aspiration.

95. How does myasthenia gravis differ from Guillain-Barré syndrome in terms of deep tendon reflexes?
Reflexes are generally normal in myasthenia gravis but decreased or absent in Guillain-Barré syndrome.

96. How does the typical weakness pattern of myasthenia gravis differ from Guillain-Barré syndrome?
Myasthenia gravis usually produces descending, fatigable weakness, whereas Guillain-Barré syndrome typically causes ascending weakness.

97. What cerebrospinal fluid finding is commonly associated with Guillain-Barré syndrome?
An elevated protein level with a relatively low white blood cell count.

98. What diagnostic studies may show slowed nerve conduction in Guillain-Barré syndrome?
Electromyography and nerve-conduction studies.

99. Why can premature ventilator weaning be especially problematic in neuromuscular disease?
Respiratory muscles may not yet have enough strength or endurance to handle the increased work of spontaneous breathing.

100. What combination of findings best indicates readiness for ventilator liberation in a recovering neuromuscular patient?
Improving respiratory muscle strength, adequate tidal volume and vital capacity, stable gas exchange, effective cough, manageable secretions, and sufficient airway protection.

Final Thoughts

Neuromuscular diseases can cause serious respiratory impairment even when lung tissue is initially normal. Weakness of the diaphragm, expiratory muscles, bulbar muscles, or neurologic pathways can reduce ventilation, weaken cough, impair airway protection, and eventually produce hypercapnic respiratory failure.

Careful assessment of vital capacity, respiratory muscle pressures, cough flow, swallowing, sleep-related ventilation, and carbon dioxide levels helps identify deterioration early.

Assisted cough techniques, lung volume recruitment, noninvasive ventilation, secretion management, adequate nutrition, and timely mechanical ventilation can reduce complications and provide essential respiratory support as neuromuscular weakness progresses.